Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Japanese Journal of Clinical Oncology|September 10, 2024
Preoperative prediction of early mortality after surgery for spinal metastasesHiroto Kamoda, Toshinori Tsukanishi, Hideyuki Kinoshita, et al.
Clinical Biochemistry|November 7, 2017
Macro-pro-B-type natriuretic peptide (proBNP) and hidden macro-N-terminal proBNP: Case reportYasuaki Nakagawa, Toshio Nishikimi, Hiroshi Sakai, et al.
Case Reports in Orthopedics|July 30, 2019
Giant Protruding Nodular Fasciitis of the Anterior Chest Wall Clinically Mimicking a Soft Tissue SarcomaHideyuki Kinoshita, Tsukasa Yonemoto, Hiroto Kamoda, et al.
General Thoracic and Cardiovascular Surgery|January 3, 2022
New strategy to resume and taper epoprostenol after lung transplant for pulmonary hypertensionAkihiro Ohsumi, Akihiro Aoyama, Hideyuki Kinoshita, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 18, 2014
Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients†Hiroshi Date, Masaaki Sato, Akihiro Aoyama, et al.
British Journal of Pharmacology|August 14, 2013
Angiotensin II type 1a receptor signalling directly contributes to the increased arrhythmogenicity in cardiac hypertrophyShinji Yasuno, Koichiro Kuwahara, Hideyuki Kinoshita, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 17, 2016
Outcomes of various transplant procedures (single, sparing, inverted) in living-donor lobar lung transplantationHiroshi Date, Akihiro Aoyama, Kyoko Hijiya, et al.
Histopathology|March 10, 2026
HMGA2 expression in CIC-rearranged sarcoma and other small round/epithelioid cell tumoursNaohiro Makise, Hajime Kageyama, Naoki Takeda, et al.
Journal of Cardiology Cases|January 8, 2024
18F-FDG PET/CT in left atrial undifferentiated pleomorphic sarcoma with osteosarcomatous differentiationYusuke Utsunomiya, Kanae K Miyake, Satsuki Fukushima, et al.
Oncology Reports|May 26, 2021
CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcomaShintaro Iwata, Yasutoshi Tatsumi, Tsukasa Yonemoto, et al.
Pageof 14